Recent Articles from GlobeNewswire

For us, this recognition validates Airia's unified approach to AI security and governance with furthest position on Completeness of Vision axis

Highest number since the pandemic year of 2021

EchoStar Corporation is officially changing its Nasdaq stock ticker symbol from "SATS" to "ECHO" Effective June 24, 2026

New stealth-driven capabilities purpose-built for Veeam environments to shield backup data, services, and execution paths from the ransomware groups now targeting backup infrastructure directly.

NEW YORK and DUBAI, United Arab Emirates, June 22, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce and engagement, today announced that its Reward platform is powering Everyday Cashback, a new Visa Card Linked Offers program launched by Mashreq in partnership with Visa.The launch represents a significant milestone for Rezolve Ai as it expands its technology footprint beyond traditional retail commerce and supports financial institutions with AI enabled payments and transaction-linked customer engagement. Through Everyday Cashback, Mashreq UAE cardholders will be able to access automated cashback offers of up to 20% at hundreds of leading merchants across the UAE and internationally.Mashreq is one of the region’s most prominent banking groups, reporting AED 335 billion, approximately US$91 billion, in total assets, AED 205 billion, approximately US$56 billion, in customer deposits, and AED 12.6 billion, approximately US$3.4 billion, in operating income for FY2025. The launch places Rezolve Ai technology inside a large-scale, regulated and high-frequency financial services environment, connected to everyday consumer spending and merchant engagement.Everyday Cashback extends the benefits of Mashreq’s award-winning Vantage Rewards ecosystem to both debit and credit cardholders for the first time. The fully digital experience enables customers to discover, activate and track cashback transactions directly through the Mashreq app, creating a seamless and transparent customer journey from offer discovery through to reward fulfilment.The program leverages advanced analytics to personalize offers for customers, helping Mashreq deliver more relevant value to cardholders while enabling participating merchants to reach a high-quality base of UAE consumers. For merchants, the platform creates a measurable commerce media channel designed to support customer acquisition, loyalty and incremental sales.By combining Visa’s payments expertise, Mashreq’s customer reach and Rezolve Ai’s Reward platform, the program demonstrates how banks, payment networks and merchants can collaborate to make everyday transactions more rewarding, personalized and commercially effective.Chiraag Jogia, Global Head of Customer Value Management at Mashreq, said:“At Mashreq, we remain committed to elevating the everyday banking experience for our customers. Everyday Cashback embodies our vision of placing innovation and customer value at the heart of everything we do. Through our partnership with Visa, we have created a seamless rewards proposition designed around the customer, making automated cashback across a wide range of leading merchants simple and accessible, and delivering a more rewarding banking experience.”Salima Gutieva, Visa’s VP and Country Manager for UAE, said:“The launch of this Visa Card Linked Offers program with Mashreq demonstrates the strong demand for this type of proposition and shows how innovation and collaboration can transform everyday payments. We are delighted to partner with Mashreq to help set a new standard for customer engagement in the UAE.”Daniel M. Wagner, Chief Executive Officer of Rezolve Ai, said:“Banks see every purchase their customers make, yet for most people that has never translated into genuinely useful, personalized offers at the right moment. That gap is exactly what Rezolve Ai is built to close. Powering Everyday Cashback alongside Mashreq and Visa, two of the most trusted names in financial services, shows that our technology creates value at the highest level. We believe making everyday spending more rewarding for consumers, and more measurable for merchants, is where the next wave of value in banking will be created, and this partnership is a strong signal we are in the right place to help build it.”For Rezolve Ai, the Mashreq launch further validates the strategic role of Reward within the Group’s broader commerce technology ecosystem. Reward is Rezolve Ai’s customer engagement and commerce media platform, operating across more than 15 markets in the UK, Europe, the Middle East and Asia. Positioned at the intersection of banking, payments and retail, Reward enables financial institutions and merchants to deliver richer customer experiences, measurable sales growth and stronger loyalty through data-driven, transaction-linked offers.The launch also reinforces the growing importance of commerce media as banks and payment networks look to create new sources of customer engagement and merchant value. By embedding personalized offers directly into payment journeys, Rezolve Ai’s technology helps turn everyday transactions into opportunities for consumers, merchants and financial institutions alike.About MashreqMashreq is more than half a century old, yet proudly thinks like a challenger, startup and innovator. Mashreq has pioneered key innovations and developments in banking, serving customers from digital-first retail users through to some of the region’s most prominent corporations and wealth accounts.The bank’s mandate is to help customers find their way to Rise Every Day, partnering through the highs and lows to help them achieve their goals and unlock their vision of success.Reassuringly present in major financial centers of the world, Mashreq’s home and global HQ remains in the Middle East, offering services whenever and wherever opportunity takes its customers. Mashreq has been recognized as the fastest-growing Middle East brand by Banking 500 rankings for 2024 by Brand Finance.About Rezolve AiRezolve Ai is a global leader in AI-powered commerce infrastructure, enabling retailers, brands, and platforms to deliver intelligent, personalized, and frictionless shopping experiences at scale. Through its proprietary Brain Suite and agentic commerce capabilities, Rezolve is redefining how consumers discover, engage, and transact in the digital economy. For more information, visit www.rezolve.com. Media ContactUrmee KhanGlobal Head of Communications 
Rezolve Aiurmeekhan@rezolve.com+44 7576 094 040Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements regarding Rezolve Ai’s strategy, market opportunity, technology capabilities, growth prospects, commercial partnerships and expected benefits of its products and platforms. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Rezolve Ai undertakes no obligation to update forward-looking statements except as required by law.

Maloney + Novotny's firm-wide Assurance Modernization plan spans financial statement audit, IT attest, and advisory services, with Fieldguide’s agentic AI-native platform serving as a unified environment to support its people, client relationships, and commitment to service excellence

Stop & Shop to release Limited-Edition White Shark Marty plushies with portion of proceeds supporting shark research, education, and conservation

Building on its origins of securing the Software Supply Chain through the natural explosion of AI, Cycode is recognized in the first ever Gartner® Magic Quadrant™ for Software Supply Chain Security, 2026 in the age of AI-driven development

This joint integration closes a longstanding visibility gap between radio-layer conditions and network operations

The new platform enables advisors to manage risk and generate alpha using covered calls and other option overlay strategies with greater efficiency and oversight

Four-year relationship spans gas detection, gas monitoring, and facility-management systems across multiple manufacturing sites, with additional projects delivered in 2026

JACKSONVILLE, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release first quarter financial and operating results after the market close on Wednesday, July 22, 2026. This will be followed by a conference call and live webcast hosted by the company’s management team at 4:30 p.m. ET.

Issued on behalf of Eagle Nuclear Energy Corp.

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Teamshares, a tech-enabled acquiror of SMEs, previously announced its completed business combination with Live Oak Acquisition Corp. V (NASDAQ: LOKV) on June 19, 2026.

Collaboration spans memory and storage AI architecture design, supply agreement, enterprise AI adoption and a strategic investment

At a glance: New Zoom Virtual Agent capabilities

ATLANTA, GA, June 22, 2026 (GLOBE NEWSWIRE) -- Yes& has acquired Modo Modo, a B2B-focused agency recognized for its work across healthcare, fintech, manufacturing, energy and technology sectors.

Novarc’s AI-powered welding automation - featuring real-time vision, adaptive control and welding intelligence - to be demonstrated at Automate 2026

Working across 150,000 healthcare providers, Prosper AI is the first platform built to combine patient scheduling, insurance verification, and patient billing while coordinating voice interactions with both patients and insurers.

HOUSTON, June 22, 2026 (GLOBE NEWSWIRE) -- This Fourth of July, the red, white and blue rolls out all week long. From June 29 through July 5, Great Escapes RV Resorts, part of the TJO 10x10 Management portfolio of outdoor hospitality destinations that includes Great Escapes, Jellystone Park™, KOA, and other affiliated properties, is lighting up the holiday with onsite fireworks, foam parties, glow parades and patriotic fun for every age, with the celebration turned up a notch for America's 250th birthday.

The FDA’s second major labeling update in 16 months — after its February 2025 removal of the cardiovascular boxed warning — marks a historic modernization of how testosterone therapy is prescribed, bringing labeling in step with a decade of new clinical evidence. Marius CEO Shalin Shah, an invited speaker at the agency’s expert panel on the therapy, helped advance the earlier change.

A former Palantir leader, McCollester will scale EnduroSat’s US operations as the company expands its footprint to serve defense, government, and commercial customers at scale

Initiative creates new resource to support and accelerate early-stage therapeutics companies

ROCHESTER, NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical technologies for vibrant end-markets - defense tech, space tech, and biomed tech today announced it received nearly $4 million in U.S. life sciences purchase orders. 

VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- SPARC AI Inc. (CSE: SPAI; OTCQB: SPAIF; Frankfurt: 5OV0) ("SPARC AI" or the "Company"), today announced it has been registered by the Australian Government as an authorized user under the AUKUS licence-free environment, a designation that lets the company move eligible defence technology to US and UK partners without a separate export permit.

Melbourne, Australia, June 22, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX | OTCQB:INNMF), (“Amplia” or the “Company”) provides a letter to shareholders from CEO and Managing Director Dr. Chris Burns outlining the potential for the Company’s best-in-class FAK inhibitor narmafotinib in combination with the emerging KRAS inhibitor class following exciting new data presented at the American Society of Clinical Oncology Annual Meeting earlier this month:

Nes-Ziona, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, "Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today provided an update on its RAIN token holdings. As of June 20, 2026, the Company held 79,568,550,005 RAIN tokens with a total value of approximately $1.14 billion1.

Live webcast on Wednesday, June 24th at 2:40 PM ET

REI Co-op and Cutler Development purchased High-Impact RECs through Ever.green, contributing to new clean electricity generation in a rural South Carolina community where energy costs consume roughly 10 percent of annual income

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to submit a New Drug Application (NDA) for EB613

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades. The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP inhibitor. DDRi therapies collectively represented an estimated $7-plus billion in global sales in 2025, and the broader oncology, diagnostics and precision medicine markets are projected to climb to roughly $750 billion by 2030. New inhibitor classes are emerging as the next major wave. Sitting at the forefront of this shift is Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF), (profile) a Canadian clinical-stage oncology company developing ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor that targets a DNA repair enzyme involved in multiple DNA repair pathways. As the field races to find the next generation of synthetic lethality assets, Onco-Innovations occupies a unique space as it strengthens its position in the biopharmaceutical and biotechnology sector, along with other leading companies, such as AstraZeneca plc (NYSE: AZN), Aprea Therapeutics Inc. (NASDAQ: APRE), Boundless Bio Inc. (NASDAQ: BOLD) and Foghorn Therapeutics Inc. (NASDAQ: FHTX), that are focused on developing therapies for serious diseases, particularly cancer.

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- via IBN -- NetworkNewsAudio announces the Audio Press Release (APR) titled “AI Infrastructure Boom Drives Demand for Semiconductor, Pharmaceutical Automation,” featuring Nightfood Holdings Inc. (OTCQB: NGTF).

Energy Safety Response Group testing found no thermal runaway, no sustained fire, and no propagation under direct flame impingement and overcharge abuse, supporting safe siting of long-duration storage in dense urban environments

Allowed claims directly support the Company’s ongoing Phase 1/2 clinical trial of CYWC628 in patients with diabetic foot ulcers

Strong Capitalization Foundation Supports Strategic Growth and Market Stability

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial results for the fiscal quarter ended May 31, 2026, on Tuesday July 7, 2026, after market close. A conference call to discuss the financial results will be held on Wednesday July 8, 2026. Details for the conference call are provided below.

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) robs people of control over their own bodies — slowly, relentlessly and without a cure. More than 2.9 million people worldwide are living with MS today, and despite decades of research, every approved treatment falls short of the same fundamental goal: stopping the disease cold. Current therapies can slow progression, but they cannot halt it, and for millions of patients, that gap means a future of worsening disability. Now, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (profile) is challenging that reality. The company is advancing Lucid-MS, a patented, first-in-class drug candidate that takes a fundamentally different approach by directly targeting the myelin sheath that MS destroys, and this new drug candidate is preparing to enter phase 2 clinical trials. Quantum BioPharma is one of several companies focused on the development and commercialization of therapies for neurological, autoimmune and immune-mediated diseases, including Sanofi (NASDAQ: SNY), Roche Holding AG (OTCQX: RHHBY), Biogen Inc. (NASDAQ: BIIB) and Clene Inc. (NASDAQ: CLNN).

Toronto, ON, June 22, 2026 (GLOBE NEWSWIRE) -- Fengate Asset Management (“Fengate”) today released its 2025 Sustainability Report, detailing how the firm continues to integrate responsible investment across its infrastructure, private equity, and real estate strategies in Canada and the United States.  

Circle8 Acquisition Establishes Global Workforce Solutions Platform Across North America and Europe

Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful completion of treatment for all participants in Part A of its ongoing Phase I/II clinical trial evaluating CMND-100 for the treatment of Alcohol Use Disorder (AUD).

– Development Partner Torii Pharmaceutical also recently announced dosing of the first Japanese patient in this trial evaluating YCANTH (TO-208) in Japan –

The Breakthrough Therapy Designation (BTD) was granted based on the positive results from the EMBRAVE Part A trial of elsunersen

-- RMAT designation granted based on Phase 1/2 clinical data, including results previously published in The New England Journal of Medicine, demonstrating PM359’s potential to address unmet need in p47phox-deficient CGD --

Refinity is developing an integrated pathway to convert mixed plastic waste into circular olefins and specialty hydrocarbon products, bypassing bio-based feedstock constraints

DALLAS, June 22, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it has partnered with Blockdaemon, a leading U.S. headquartered institutional-grade crypto infrastructure company, to support their Hyperliquid staking operations through the Kinetiq X Hyperion Validator.

Eight New Patents Issued on Heart Failure Technology

The Next Generation of DaySavers' Best-Selling Cone Filling Machine Arrives Just as Pre-Rolls Overtake Flower as Cannabis' #1 Product, Making Homemade Joints Accessible to All

SINGAPORE, June 22, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that on June 22, 2026, its board of directors approved a share repurchase program, pursuant to which the Company may repurchase up to US$5 million worth of its Class A ordinary shares, par value $0.0001 per share, during a 24-month period starting from June 24, 2026. The share repurchase program aims to demonstrate the Company’s confidence in its long-term business prospect and to deliver value to shareholders.

Phase 1/2 SSc study is expected to enroll patients at over 20 participating clinical sites in at least five countries

HARTSVILLE, S.C., June 22, 2026 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”)(NYSE: SON), a global leader in high-value sustainable packaging, will announce second quarter 2026 results on Wednesday, July 22, 2026 after the market closes. The Company will host a conference call to discuss these results on Thursday, July 23, 2026 at 8:00 a.m. Eastern Time.

VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. (“Westport") (TSX:WPRT / Nasdaq: WPRT), today announced that it has entered into a definitive securities purchase agreement for the purchase and sale of 4,854,369 common shares (or pre-funded warrants in lieu thereof) in a registered direct offering and, in a concurrent private placement, warrants to purchase up to 4,854,369 common shares, priced at-the-market under Nasdaq rules. The combined effective purchase price for each common share (or pre-funded warrant in lieu thereof) and associated private placement warrant is US$2.06. The private placement warrants have an exercise price of US$2.06 per common share, will be immediately exercisable and will expire two years following the date of issuance. Subject to limited exceptions, a holder of warrants will not have the right to exercise any portion of its warrants if the holder would beneficially own in excess of 9.99% of the number of Westport common shares outstanding immediately after giving effect to such exercise.

Appointments deepen operational leadership for commercial expansion and market positioning as Veea rapidly scales its AI-native edge infrastructure platform

Procedures follow Health Canada Medical Device License for the Company’s advanced neurovascular portfolio

Kandi’s International Off-Road Vehicle Business Reaches Customers in 35 Countries and Regions, Expanding in Africa, Southeast Asia, Latin America and the Middle East Alongside Robust Momentum in the North American Market

MCDONALD, Tenn., June 22, 2026 (GLOBE NEWSWIRE) -- Amaero Inc. (ASX:3DA, OTCX:AMROF) (“Amaero” or the “Company”), leading U.S. domestic producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing, and a leader in PM-HIP (Powder Metallurgy Hot Isostatic Pressing) manufacturing is pleased to announce that it has completed commissioning of the 3rd advanced Electrode Induction Melting Inert Gas Atomizer (EIGA Premium) ahead of schedule1 at its flagship Tennessee manufacturing facility.

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- NordLayer, a toggle-ready network security platform for business, today announced it has been recognized in the Expert Insights Cybersecurity Awards Summer 2026, named among the top solutions in the Network Security category.

DENVER, June 22, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration,” “GrowGen” or “the Company”), one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and garden centers, today announced that management will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, to be held on June 23–24, 2026.

Completed dosing of 17 patients in REVEAL pivotal trial; topline data from 6‑month interim analysis and FDA feedback on next steps toward BLA submission pathway expected 1H 2027

Enrollment expected to complete Q1 2027; topline results anticipated 1H 2028; BLA filing targeted for 2H 2028

Showcased at the annual AACI-CRI meeting, a new Academic Site Advisory Board will work to bridge the gap between clinical research and clinical care at academic medical centers

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs. and DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced a collaboration between DiamiR and AlzLabs Precision Diagnostics (“AlzLabs”) to generate protein and microRNA blood-based biomarker data with the focus on Alzheimer’s disease.

EMERYVILLE, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today announced the appointment of Ritesh Srivastava as Chief Legal and Compliance Officer, effective June 22, 2026. Mr. Srivastava brings extensive experience spanning legal, corporate strategy, compliance, and risk management, which will further support Kyverna as it advances miv-cel (mivocabtagene autoleucel, KYV-101) towards a potential first approval in stiff person syndrome and transitions to a commercial-stage organization.

DENVER, June 22, 2026 (GLOBE NEWSWIRE) -- BiggerPockets, the premier community and resource hub for real estate investors (REIs), today announced the appointment of experienced operator and active real estate investor Eric Augustyn as Chief Executive Officer.

As the Fed’s 2026 Report on Employer Firms confirms capital access remains a top barrier for small business owners, CredFin, Inc. is equipping entrepreneurs nationwide with the tools to qualify for funding

DALIAN, China, June 22, 2026 (GLOBE NEWSWIRE) -- On June 20, the highly anticipated first home fixture of Dalian in the 2026 Northeast China Super Football League kicked off in spectacular fashion at Suoyuwan Football Stadium.

The utility solutions company marked milestone with June 18 celebration, reflecting on a century of expansion.

FAIR HAVEN, N.J. and ITHACA, N.Y., June 22, 2026 (GLOBE NEWSWIRE) -- TETmedical, Inc., a clinical stage medical diagnostics company developing rapid tools for diagnosing acute neurological injury based on its patented Tethered Enzyme Technology (TET), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its NSE-FAST® (Neuron Specific Enolase — Functional Activity Stroke Test), a rapid in vitro diagnostic assay intended to aid in the diagnosis of acute ischemic stroke.

PALO ALTO, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced today that additional positive data from PROPEL 3, the global Phase 3 pivotal study of oral infigratinib in children living with achondroplasia, will be shared in a late breaking oral presentation at the International Congress of Children’s Bone Health (ICCBH) 2026 taking place in Montreal, Canada on June 27-30, 2026.

Fort Lee, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today announced a strategic portfolio expansion via a license agreement for exclusive ex-China rights with Haisco Pharmaceutical Group (“Haisco”) to two potentially best in-class clinical-stage compounds. Nuvectis will hold a conference call today at 8:30 AM ET to introduce its newly in-licensed products.

FDA’s rolling review process is intended to facilitate expedited review, enabling FDA to begin evaluating completed sections of the NDA before the full application is submitted

WINTER PARK, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ: STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the third yield payment for GLDY, its gold-backed, yield-bearing tokenized security, occurred on June 18th, 2026. The distribution covers the period from May 1st through May 31st, 2026.

Company’s presentation will provide updates on SkinJect® Phase 2b Pivotal Study in patients with Gorlin Syndrome and Teverelix® Groundbreaking PRECISION-E2 Phase 2a Endometriosis Study leveraging the UAE Genome Program

IRVINE, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Blue Sky, the #1 dated goods brand in the U.S., is proud to introduce Your Year, a new line of age-appropriate planners and notebooks for students and their parents.

BELVIDERE, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products today announced that its Pickle Party™ product line has been named the 2026 Mindful Award Winner for Overall Plant-Based Snack Product of the Year by the Mindful Awards, an independent recognition program honoring excellence in mindful consumer packaged goods and products.

Nes Ziona, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure today announced that Dagi Ben-Noon, Chief Executive Officer of QTREX, Tal Parnas, Chairman of the Company’s Board of Directors, and members of the Company’s senior management team have informed QTREX’s Board of Directors of their intention to use personal funds to purchase up to an aggregate of 2,000,000 of the Company’s ordinary shares, no par value per share (the “Ordinary Shares”) over the next 12 months from June 22, 2026, pursuant to and subject to applicable rules and regulations as well as the Company’s insider trading policy.